Click image to enlarge
The V-PLEX SARS-CoV-2 Panel 12 (IgG) Kit is a multiplex serology assay for antibodies to ten RBD antigens from variants of SARS-CoV-2, including the Delta, Lambda, and several emerging variants. Panel 12 has RBD antigens from the following lineages: A (WT), (AY.3), (AY.4), (AY.5), (AY.6), (AY.7), (AY.12), (AY.14), (A.23.1), (A.VOI.V2), (B.1.1.519), (B.1.525), (B.1.526), (B.1.617), (B.1.617.1), (B.1.617.2), (B.1.617.2+∆144), (B.1.617.3), (BV-1), (C.37), (P.2), (P.3), and (R.1).
-
Specifications
-
Kit Contents
-
-
References
-
Documentation
|
Analyte(s)
|
|
SARS-CoV-2 S1 RBD, SARS-CoV-2 S1 RBD (E484K), SARS-CoV-2 S1 RBD (E484K, N501Y), SARS-CoV-2 S1 RBD (L452Q, F490S), SARS-CoV-2 S1 RBD (L452R, E484Q), SARS-CoV-2 S1 RBD (L452R, T478K), SARS-CoV-2 S1 RBD (Q493R, N501Y), SARS-CoV-2 S1 RBD (R346K, T478R, E484K), SARS-CoV-2 S1 RBD (T478K), SARS-CoV-2 S1 RBD (V367F)
|
|
|
Species
|
|
Human
|
|
|
Instrument
|
|
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
,
SECTOR Imager 2400
,
SECTOR Imager 6000
|
|
|
Plate Type
|
|
96-well
|
|
|
Sample Type
|
|
Serum, Plasma, Saliva, Upper Respiratory Sample
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
1 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 12
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
2-8 °C
|
1 bottle
(1000 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Serology Control 1.1
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.2
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Serology Control 1.3
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
Reference Standard 1
|
≤-70 °C
|
5 vial
(1 mL)
|
|
|
|
|
2-8 °C
|
5 vial
(5 plate size)
|
|
|
|
SARS-CoV-2 Plate 12
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
|
2-8 °C
|
5 bottle
(1000 mL)
|
|
|
|
|
RT
|
5 bottle
(90 mL)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
MSD Blocker A
|
RT
|
5 bottle
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Title
|
Journal
|
Year
|
|
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination
|
|
|
|
Quantitative serology for SARS-CoV-2 using self-collected saliva and finger-stick blood
|
|
|
|
Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay
|
|
|
|
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 months
|
|
|
|
Humoral Response Dynamics Following Infection with SARS-CoV-2
|
|
|
|
|
|
|
Product Inserts
|
|
|
|
Handouts
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters